Doctors doubt effect of new Covid-19 tablet
Covid-19 tablet treatment Lagevrio (molnupiravir), which the Danish Health Authority allowed on Thursday despite it having yet to be approved by the EMA, might not work at all, say Danish health experts.
by RITZAU, translated by daniel pedersen
On Thursday, the Danish Health Authority allowed doctors in the country to use MSD's tablet treatment, Lagevrio (molnupiravir), to treat patients at risk of severe Covid-19 infections.
Already a subscriber?Log in here
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
With your free trial you get:
- Access all locked articles
- Receive our daily newsletters
- Access our app
Get full access for you and your coworkers
Start a free company trial todayRelated articles:
EMA allows emergency use of MSD's Covid-19 capsule treatment
For subscribers
.jpg&w=384&q=75)
